Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2016, Article ID 9364091, 10 pages
http://dx.doi.org/10.1155/2016/9364091
Review Article

The Endocannabinoid System as a Therapeutic Target in Glaucoma

1Department of Pharmacology, Dalhousie University, Halifax, NS, Canada B3H 4R2
2Department of Medical Neuroscience, Dalhousie University, Halifax, NS, Canada B3H 4R2
3Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, NS, Canada B3H 4R2

Received 10 July 2015; Accepted 10 November 2015

Academic Editor: Maurice Ptito

Copyright © 2016 Elizabeth A. Cairns et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • James T. Toguri, Meggie Caldwell, and Melanie E. M. Kelly, “Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain,” Frontiers in Pharmacology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • R Le Boisselier, J Alexandre, V Lelong-Boulouard, and D Debruyne, “Focus on cannabinoids and synthetic cannabinoids,” Clinical Pharmacology & Therapeutics, 2016. View at Publisher · View at Google Scholar
  • Rita Maccarone, Cinzia Rapino, Monia Di Tommaso, Natalia Battista, Silvia Bisti, Darin Zerti, Stefano Di Marco, and Mauro Maccarrone, “Modulation of Type-1 and Type-2 cannabinoid receptors by saffron in a rat model of retinal neurodegeneration,” PLoS ONE, vol. 11, no. 11, 2016. View at Publisher · View at Google Scholar
  • Irantzu Rico-Barrio, Aresatz Usobiaga, Oier Aizpurua-Olaizola, Izaskun Elezgarai, Iratxe Zarandona, and Nestor Etxebarria, “Targeting the endocannabinoid system: future therapeutic strategies,” Drug Discovery Today, vol. 22, no. 1, pp. 105–110, 2016. View at Publisher · View at Google Scholar
  • Raffaele Nuzzi, and Federico Tridico, “Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis,” Frontiers in Neuroscience, vol. 11, 2017. View at Publisher · View at Google Scholar
  • Elizabeth A. Cairns, Anna-Maria Szczesniak, Alex J. Straiker, Pushkar M. Kulkarni, Roger G. Pertwee, Ganesh A. Thakur, William H. Baldridge, and Melanie E.M. Kelly, “ The In Vivo Effects of the CB 1 -Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice ,” Journal of Ocular Pharmacology and Therapeutics, 2017. View at Publisher · View at Google Scholar
  • Xing-Hui Zhang, Mei-Xiang Li, Peng-Cheng He, Qi-Xian Tian, Laudon Moshe, Yao Zhang, Jin-Feng Shi, Mei-Hua She, and Wei-Dong Yin, “Neu-P11 reduces IOP through inhibiting oxidative stress level of acute high IOP rats,” Chinese Pharmacological Bulletin, vol. 33, no. 5, pp. 637–641, 2017. View at Publisher · View at Google Scholar
  • Laura R. Caltana, and Alicia Brusco, “Cannabinoids: A Group of Promising Neuroprotective Agents,” Neuroprotective Natural Products, pp. 321–339, 2017. View at Publisher · View at Google Scholar
  • Yunes Panahi, Azadeh Manayi, Marjan Nikan, and Mahdi Vazirian, “The arguments for and against cannabinoids application in glaucomatous retinopathy,” Biomedicine & Pharmacotherapy, vol. 86, pp. 620–627, 2017. View at Publisher · View at Google Scholar
  • Goran Pelčić, Rudolf Ljubičić, Dubravka Biuk, Josip Barać, and Veljko Rogoić, “Glaucoma, depression and quality of life: Multiple comorbidities, multiple assessments and multidisciplinary plan treatment,” Psychiatria Danubina, vol. 29, no. 3, pp. 351–359, 2017. View at Publisher · View at Google Scholar
  • Natascia Bruni, Carlo Della Pepa, Simonetta Oliaro-Bosso, Enrica Pessione, Daniela Gastaldi, and Franco Dosio, “Cannabinoid Delivery Systems for Pain and Inflammation Treatment,” Molecules, vol. 23, no. 10, pp. 2478, 2018. View at Publisher · View at Google Scholar
  • Gilberto Spadoni, Annalida Bedini, Lucia Furiassi, Michele Mari, Marco Mor, Laura Scalvini, Alessio Lodola, Andrea Ghidini, Valeria Lucini, Silvana Dugnani, Francesco Scaglione, Daniele Piomelli, Kwang-Mook Jung, Claudiu T. Supuran, Laura Lucarini, Mariaconcetta Durante, Silvia Sgambellone, Emanuela Masini, and Silvia Rivara, “Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit,” Journal of Medicinal Chemistry, 2018. View at Publisher · View at Google Scholar
  • Wafa Hourani, and Stephen P. H. Alexander, “Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential,” Brain and Neuroscience Advances, vol. 2, pp. 239821281878390, 2018. View at Publisher · View at Google Scholar
  • Yu-Jin Kwon, Ji-Hye Kim, and Dong-Hyuk Jung, “Association Between Nonalcoholic Fatty Liver Disease and Intraocular Pressure in Korean Adults,” Journal of Glaucoma, vol. 27, no. 12, pp. 1099–1104, 2018. View at Publisher · View at Google Scholar
  • Pedro Lax, Oksana Kutsyr, Gema Esquiva, Cesare Altavilla, Victoria Maneu, and Nicolás Cuenca, “Cannabinoid-mediated retinal rescue correlates with improved circadian parameters in retinal dystrophic rats,” Experimental Eye Research, 2018. View at Publisher · View at Google Scholar
  • Joel Ehrenkranz, and Michael A Levine, “Bones and Joints: The Effects of Cannabinoids on the Skeleton,” The Journal of Clinical Endocrinology & Metabolism, vol. 104, no. 10, pp. 4683–4694, 2019. View at Publisher · View at Google Scholar